Mutations in the parkin gene (PRKN, PARK2) cause autosomal-recessive early-onset Parkinson's disease (PD). Reported parkin mutation frequencies vary across studies, but percentages up to 49% of familial and 20% of sporadic cases of early-onset PD have been reported on. [1][2][3][4] It is difficult to clinically distinguish parkin mutations from other causes of PD. Clinical clues for mutations in the parkin gene are symmetrical onset, dystonia, hyperreflexia, slower disease progression, and a good response to levodopa. In this report, we describe a 35-year-old Dutch man with "foot drop dystonia" resulting from a parkin mutation.
Case DescriptionThe patient was referred to our neurology outpatient clinic with a gait disorder. He had progressive difficulties with walking for 6 years. He complained of walking bent over with his legs apart. While walking, it felt like his feet dropped to the floor. His complaints worsened during the day and during exercise. In the beginning, he only experienced this during strenuous effort, especially while playing football. He ran straddle-legged on the lateral sides of his feet. He recovered in half an hour. At the end, playing football was not possible anymore. He also experienced trembling in his legs during walking and worsening with emotions and exhaustion. His girlfriend noticed a mumbled speech. He reported a restless sleep with flailing and kicking during sleep. Family history was negative for neurological or psychiatric disorders. There was no parental consanguinity. He has one healthy sister and no brothers or children.Neurological examination on admission showed a monotonous voice, minimal hypomimia, mild general rigidity, and minimal bradykinesia during finger tapping. He walked with exaggerated lifting and subsequently dropping of the feet, slightly with the legs apart, which we classified as a dystonic gait (see Video 1). Dopa-responsive dystonia (DRD) was in our differential diagnosis, because of worsening during the day and the combination of foot dystonia with some bradykinesia.5 Importantly, mild parkinsonism may occur in DRD. 6 Indeed, L-dopa/carbidopa 100/25 mg three times daily appeared successful. Brain MRI showed no abnormalities. Cerebrospinal fluid (CSF) analysis showed normal concentrations of biopterin, neopterin, and homovanillic acid (however, during L-dopa treatment). Genetic tests for mutations in the genes for guanosin triphosphate cyclohydrolase 1 (GCH1, DYT5), sepiapterin reductase (SPR), and tyrosin hydroxylase (TH) were negative. A dopamine transporter imaging with single-photon emission computed tomography (DAT SPECT) scan showed bilateral and asymmetrical loss of striatal DAT binding with the right striatum showing the largest loss (Figure 1). Finally, multiplex litigation-dependent probe amplification showed a compound heterozygous parkin mutation (i.e., deletion exons 3-6 and deletion exon 3).To prevent early development of L-dopa-induced dyskinesia, which is more common in patients with parkin mutations, 4 L-dopa/carbidopa was replaced by pram...